✨ Free AI Report
B. Braun SE: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research B. Braun SE
Company Research

B. Braun SE: Business Overview, Financials & Competitive Analysis

B. Braun SE scores 7/10 on the AskCyborg Cyborg Score (Strong). Diversified medical device leader with strong innovation pipeline and global distribution, facing near-term regulatory and supply chain challenges but positioned for recovery through digital surgery expansion and product safety enhancements.

What is B. Braun SE's industry? B. Braun SE (bbraun.com) operates in Medical Devices. AskCyborg classifies B. Braun SE under Medical Devices in its company registry.

B. Braun SE is a medical technology company that manufactures medical devices and pharmaceutical products, including infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis ...

7/ 10Strong

Cyborg Score thesis

Diversified medical device leader with strong innovation pipeline and global distribution, facing near-term regulatory and supply...

Read the full analyst-debate transcript →
Industry Medical Devices
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest B. Braun SE Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for B. Braun SE

AskCyborg analysts argue the bull and bear cases for B. Braun SE across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
B. Braun SE OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

B. Braun SE Overview

Pro stress-test →

B. Braun SE is a medical technology company that manufactures medical devices and pharmaceutical products, including infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and ostomy, disinfection, and wound care products. Founded in 1839, the company remains family-owned by the Braun family and has over 63,000 employees worldwide operating offices and production facilities in more than 60 countries.

Strategic Profile

Pro stress-test →

B. Braun operates through three divisions: Hospital Care (infusion, nutrition, pain therapy, and regional anesthesia focus), Aesculap (surgical and interventional treatment), and Avitum (renal care). The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety.

Competitive Landscape

Pro stress-test →

B. Braun competes in a concentrated market dominated by Medtronic ($36.4B revenue), Johnson & Johnson ($33.8B), and Abbott ($30.3B). B. Braun differentiates through specialized product lines (infusion therapy, dialysis, regional anesthesia) and its integrated three-division structure across Hospital Care, surgical (Aesculap), and renal care (Avitum), targeting hospital and healthcare provider segments.

Industry Context

B. Braun SE operates in Medical Devices.

Key facts

Founded: 1839 · Headquarters: Melsungen, Germany · Employees: 63,000 · Revenue: €9.14B · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for B. Braun SE.

  • B. Braun acquired True Digital Surgery (September 2025) to expand its digital microsurgery portfolio and strengthen its Aesculap surgical division, having previously held a minority stake.
  • FDA issued an early alert (March 2026) for certain Streamline Airless System Hemodialysis Bloodlines and B3 Low Volume Bloodlines due to manufacturing defect with tubing resin changes causing air bubbles in arterial bloodlines.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026FDA early alert issued for hemodialysis bloodlines due to tubing resin defect
  • September 2025B. Braun acquired True Digital Surgery to expand robotic microsurgery capabilities
  • +2 moreTrack every material event for B. Braun SE as it happens. Explore monitoring →
Get alerted when B. Braun SE has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Infusion & Renal ProductsHealthcare services with infusion therapy and renal care products→Surgical Instruments & DevicesLeading medical device manufacturer with broad surgical and diagnostic portfolio→Medical Devices & PharmaceuticalsDiversified healthcare company with medical devices, pharmaceuticals, and consumer health→IV Solutions & InfusionIV fluids, infusion therapy, and renal care solutions→

Compare B. Braun SE with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

B. Braun SE operates in Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices research →
NEW · MCP server

Ask your AI assistant about B. Braun SE

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare B. Braun SE and its top competitor on Cyborg Score”
“What did B. Braun SE do this quarter?”
“Is B. Braun SE a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does B. Braun SE do?+
B. Braun SE is a medical technology company that manufactures medical devices and pharmaceutical products, including infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis ...
What is B. Braun SE's Cyborg Score?+
B. Braun SE has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are B. Braun SE's main competitors?+
Named competitors include Infusion & Renal Products, Surgical Instruments & Devices, Medical Devices & Pharmaceuticals, IV Solutions & Infusion. The full competitive landscape is in the AskCyborg report.
How can I get the full B. Braun SE research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the B. Braun SE research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track B. Braun SE over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Ambu A/S6Anika Therapeutics, Inc.6Pulse Biosciences, Inc.6Supermax Corporation Berhad5PolyNovo Limited4Know Labs, Inc.3SeaStar Medical Holding Corporation2Talis Biomedical Corporation